Susquehanna Portfolio Strategies, LLC
Position in PSNL — Personalis, Inc.
CIK 1996449
Bala Cynwyd, PA
Position in PSNL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,625,406
+$1,234,976 QoQ
Shares Held
121,299
+97.9% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 158 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $90,460,548 across 7 Diagnostics & Research names. PSNL ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
350,725 | $46,586,801 | |
| 2 | GH |
Guardant Health, Inc.
|
155,346 | $23,306,560 | |
| 3 | DGX |
Quest Diagnostics Inc
|
60,404 | $12,802,627 | |
| 4 | GRAL |
GRAIL, Inc.
|
71,088 | $4,853,177 | |
| 5 | PSNL |
Personalis, Inc.
This page
|
121,299 | $1,625,406 | |
| 6 | CDNA |
CareDx, Inc.
|
45,122 | $1,285,977 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
219,151 | $0 |
All Filings in PSNL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,625,406 | 121,299 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $390,430 | 61,292 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $492,278 | 61,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $403,222 | 61,844 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $314,512 | 47,944 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $75,156 | 21,412 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||